Brief: Chemomab Therapeutics Announces Appointment Of Dale Pfost As Chief Executive Officer
Sept 2 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS ANNOUNCES APPOINTMENT OF DALE PFOST
AS
CHIEF EXECUTIVE OFFICER
* CHEMOMAB THERAPEUTICS LTD - ADI MOR WILL CONTINUE IN HER
ROLE AS
CHIEF SCIENTIFIC OFFICER AND REMAIN AS BOARD MEMBER
Source text for Eikon: ID:nPn5CCSmja
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update